Skip to content
StockMarketAgent
Healthcare / Medical DistributionUpdated 2026-05-10 22:07 UTC

ASX/MYX stock hub

ASX/MYX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ASX/MYXis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
209.6M
Australian Securities Exchange
Market data

Live price

Current market quote for this ticker.

Current price
ASX/MYX
In the news

Latest news · ASX/MYX

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.9P50 20.4P75 41.2
Trailing P/En/a
P25 14.2P50 19.2P75 35.1
ROE-20.6
P25 -118.7P50 -49.4P75 -1.2
ROIC-11.7
P25 -74.7P50 -33.5P75 0.1
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ASX/MYX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
205
Groups with data
11
Currency
AUD
Showing 205 of 205 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Australia
Country code
AU
Employees
491
Employees Change
-509%
Employees Change Percent
-50.9
Enterprise value
AUD 184.6M
Exchange
Australian Securities Exchange
Financial currency
AUD
First seen
2026-05-10
Industry
Medical Distribution
Isin
AU000000MYX0
Last refreshed
2026-05-10
Market cap
AUD 209.6M
Price
AUD 2.58
Price currency
AUD
Rev Per Employee
829,146.64x
Sector
Healthcare
Sic
2834
Symbol
asx/MYX
Website
https://www.maynepharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

8
MetricValue
Earnings Yield
-39.71%
EV Earnings
-2.22x
EV/EBITDA
6.11x
EV/FCF
12.36x
EV/Sales
0.45x
FCF yield
7.12%
P/B ratio
0.59x
P/S ratio
0.51x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

22
MetricValue
EBIT Margin
-9.38%
EBITDA Margin
6.58%
FCF margin
3.67%
Gross margin
62.64%
Gross Profit
AUD 255M
Gross Profit Growth
3.12%
Gross Profit Growth Q
5.9%
Gross Profit Growth3 Y
5.24%
Gross Profit Growth5 Y
63.2%
Net Income
AUD -83.2M
Net Income Growth Quarters
6%
Net Income Growth Years
1%
Pretax Margin
-15.48%
Profit Margin
-20.44%
Profit Per Employee
AUD -169,511
ROA
-2.3
Roa5y
-4.09
ROCE
-5.59
ROE
-20.58
Roe5y
-32.73
ROIC
-11.65
Roic5y
-13.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

17
MetricValue
Cagr10y
-19.52%
Cagr15y
-6.45%
Cagr1y
-63.69%
Cagr3y
-14.99%
Cagr5y
-18.58%
Div CAGR10
-26.61%
Div CAGR3
-64.34%
Div CAGR5
-46.14%
EPS Growth Quarters
6
EPS Growth Years
2
OCF Growth
5,436.57%
OCF Growth10 Y
-15.2%
Revenue Growth
-1.55x
Revenue Growth Q
-0.46x
Revenue Growth Years
3x
Revenue Growth3 Y
1.58x
Revenue Growth5 Y
47.16x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
AUD 0.39
Assets
AUD 940.6M
Cash
AUD 67.4M
Current Assets
AUD 341.1M
Current Liabilities
AUD 257.4M
Debt
AUD 42.5M
Debt EBITDA
AUD 1.4
Debt Equity
AUD 0.12
Debt FCF
AUD 2.84
Equity
AUD 352.7M
Interest Coverage
-0.96
Liabilities
AUD 587.8M
Long Term Assets
AUD 599.4M
Long Term Liabilities
AUD 330.5M
Net Cash
AUD 25M
Net Cash By Market Cap
AUD 11.92
Net Cash Growth
-70.62%
Net Debt EBITDA
AUD -0.93
Net Debt Equity
AUD -0.07
Net Debt FCF
AUD -1.67
Tangible Book Value
AUD -147.1M
Tangible Book Value Per Share
AUD -1.81
WACC
20.82

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.33
Inventory Turnover
2.8
Net Working Capital
AUD 56.6M
Quick ratio
1.01
Working Capital
AUD 83.7M
Working Capital Turnover
AUD 3.93

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
-0.43%
Dividend per share
AUD 0
Last Dividend
AUD 0.03

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-88.59%
1Y total return
-63.66%
200-day SMA
3.79
3Y total return
-38.57%
50-day SMA
2.44
50-day SMA vs 200-day SMA
50under200
5Y total return
-64.22%
All Time High
42.2
All Time High Change
-93.89%
All Time High Date
2016-08-15
All Time Low
2.04
All Time Low Change
26.47%
All Time Low Date
2026-03-20
ATR
0.13
Beta
1.04
Beta1y
-0
Beta2y
0.47
Ch YTD
-17.04
High
2.59
High52
7.14
High52 Date
2025-05-09
High52ch
-63.97%
Low
2.55
Low52
2.04
Low52 Date
2026-03-20
Low52ch
26.47%
Ma50ch
5.61%
Price vs 200-day SMA
-31.91%
RSI
50.54
RSI Monthly
38.01
RSI Weekly
38.27
Sharpe ratio
-0.86x
Sortino ratio
-0.97
Total Return
-0.43%
Tr YTD
-17.04
Tr15y
-63.2%
Tr1m
11.69%
Tr1w
-7.19%
Tr3m
-1.9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
AUD -38.2M
Operating margin
-9.38

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
67,603,179%
Net Borrowing
-3,499,000
Shares Insiders
8.62%
Shares Institutions
42.96%
Shares Out
81,245,827
Shares Qo Q
0.34%
Shares Yo Y
0.43%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
AUD 12M
Average Volume
331,406.3x
Bv Per Share
4.34
CAPEX
AUD -6.7M
Ch10y
-89.97
Ch15y
-67.63
Ch1m
11.69
Ch1w
-7.19
Ch1y
-63.66
Ch3m
-1.9
Ch3y
-38.57
Ch5y
-68.54
Ch6m
-47.35
Change
-0.77%
Change From Open
0
Close
2.6
Days Gap
-0.77
Depreciation Amortization
64,970,000
Dollar Volume
322,035.6
Earnings Date
2026-05-22
EBIT
AUD -38.2M
EBITDA
AUD 26.8M
EPS
AUD -1.05
F Score
4
FCF
AUD 14.9M
FCF EV Yield
8.09x
FCF Per Share
AUD 0.18
Financing CF
-1,229,000
Fiscal Year End
June
Founded
2,005
Income Tax
AUD 19.2M
Investing CF
-4,897,000
Is Primary Listing
1
Last Earnings Date
2026-02-22
Last Report Date
2025-12-31
Last Split Date
2023-01-18
Last Split Type
Reverse
Ma150
3.36
Ma150ch
-23.19%
Ma20
2.6
Ma20ch
-0.73%
Net CF
13,637,000
Next Earnings Date
2026-05-22
Open
2.58
P FCF Ratio
14.04
P OCF Ratio
9.68
Position In Range
75
Ppne
57,112,000
Price Date
2026-05-08
Price EBITDA
AUD 7.83
Relative Volume
0.38x
Revenue
407,111,000x
SBC By Revenue
0.72x
Share Based Comp
2,931,000
Tax By Revenue
4.71x
Tr6m
-47.35%
Volume
124,820
Z Score
-0.72
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does ASX/MYX pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/MYX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-63.7%
S&P 500 1Y: n/a
3Y total return
-38.6%
S&P 500 3Y: n/a
5Y total return
-64.2%
S&P 500 5Y: n/a
10Y total return
-88.6%
S&P 500 10Y: n/a
Ownership

Who owns ASX/MYX?

Insider, institutional, and short-interest positioning.

Institutional ownership
+43.0%
Share of float held by funds and institutions
Insider ownership
+8.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.4%
Negative means the company is buying back shares.
Technical

ASX/MYX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
50.5
Neutral momentum band
Price vs 200-day MA
-31.9%
50/200-day relationship not available
Beta (5Y)
1.04
Moves roughly with the market
Sharpe ratio
-0.86
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ASX/MYX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/MYX stock rating?

asx/MYX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/MYX analysis?

The full report lives at /stocks/asx/MYX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/MYX?

The latest report frames asx/MYX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/MYX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.